BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8262922)

  • 1. Membrane fusion-inhibiting peptides do not inhibit influenza virus fusion or the Ca(2+)-induced fusion of negatively charged vesicles.
    Stegmann T
    J Biol Chem; 1993 Dec; 268(36):26886-92. PubMed ID: 8262922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Sendai virus fusion with phospholipid vesicles and human erythrocyte membranes by hydrophobic peptides.
    Kelsey DR; Flanagan TD; Young JE; Yeagle PL
    Virology; 1991 Jun; 182(2):690-702. PubMed ID: 1850923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide inhibitors of enveloped virus infection inhibit phospholipid vesicle fusion and Sendai virus fusion with phospholipid vesicles.
    Kelsey DR; Flanagan TD; Young J; Yeagle PL
    J Biol Chem; 1990 Jul; 265(21):12178-83. PubMed ID: 2165053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane fusion activity of influenza virus. Effects of gangliosides and negatively charged phospholipids in target liposomes.
    Stegmann T; Nir S; Wilschut J
    Biochemistry; 1989 Feb; 28(4):1698-704. PubMed ID: 2719929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of membrane fusion by lysophosphatidylcholine.
    Yeagle PL; Smith FT; Young JE; Flanagan TD
    Biochemistry; 1994 Feb; 33(7):1820-7. PubMed ID: 8110784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the 'fusion peptide' from measles virus on the structure of N-methyl dioleoylphosphatidylethanolamine membranes and their fusion with Sendai virus.
    Yeagle PL; Epand RM; Richardson CD; Flanagan TD
    Biochim Biophys Acta; 1991 May; 1065(1):49-53. PubMed ID: 1646029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of simian immunodeficiency virus with liposomes and erythrocyte ghost membranes: effects of lipid composition, pH and calcium.
    Larsen CE; Alford DR; Young LJ; McGraw TP; Düzgüneş N
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():1947-55. PubMed ID: 2120385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine.
    Günther-Ausborn S; Praetor A; Stegmann T
    J Biol Chem; 1995 Dec; 270(49):29279-85. PubMed ID: 7493959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane penetration of Sendai virus glycoproteins during the early stages of fusion with liposomes as determined by hydrophobic photoaffinity labeling.
    Novick SL; Hoekstra D
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7433-7. PubMed ID: 2845406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of Sendai virus with negatively charged liposomes as studied by pyrene-labelled phospholipid liposomes.
    Amselem S; Barenholz Y; Loyter A; Nir S; Lichtenberg D
    Biochim Biophys Acta; 1986 Aug; 860(2):301-13. PubMed ID: 3017417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane vesicles containing the Sendai virus binding glycoprotein, but not the viral fusion protein, fuse with phosphatidylserine liposomes at low pH.
    Chejanovsky N; Zakai N; Amselem S; Barenholz Y; Loyter A
    Biochemistry; 1986 Aug; 25(17):4810-7. PubMed ID: 3021204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane destabilization by N-terminal peptides of viral envelope proteins.
    Düzgüneş N; Shavnin SA
    J Membr Biol; 1992 May; 128(1):71-80. PubMed ID: 1323686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses.
    Colpitts CC; Ustinov AV; Epand RF; Epand RM; Korshun VA; Schang LM
    J Virol; 2013 Apr; 87(7):3640-54. PubMed ID: 23283943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion and infection of influenza and Sendai viruses as modulated by dextran sulfate: a comparative study.
    Ramalho-Santos J; de Lima MC
    Biosci Rep; 2001 Jun; 21(3):293-304. PubMed ID: 11892996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane fusion and the lamellar-to-inverted-hexagonal phase transition in cardiolipin vesicle systems induced by divalent cations.
    Ortiz A; Killian JA; Verkleij AJ; Wilschut J
    Biophys J; 1999 Oct; 77(4):2003-14. PubMed ID: 10512820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation by radiation inactivation of the size of functional units governing Sendai and influenza virus fusion.
    Bundo-Morita K; Gibson S; Lenard J
    Biochemistry; 1987 Sep; 26(19):6223-7. PubMed ID: 2825775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of osmotic forces in fusion of enveloped viruses with intact human erythrocytes: studies with Sendai and influenza virus particles.
    Citovsky V; Shoshani-Gilad R; Loyter A
    Prog Clin Biol Res; 1990; 343():133-45. PubMed ID: 2165614
    [No Abstract]   [Full Text] [Related]  

  • 18. Fusion of phosphatidylethanolamine-containing liposomes and mechanism of the L alpha-HII phase transition.
    Ellens H; Bentz J; Szoka FC
    Biochemistry; 1986 Jul; 25(14):4141-7. PubMed ID: 3741846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of influenza virus with sialic acid-bearing target membranes.
    Alford D; Ellens H; Bentz J
    Biochemistry; 1994 Mar; 33(8):1977-87. PubMed ID: 8117654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.